, Institut national de la statistique et des études économiques. Population par âge. Février, 2018.

E. Fabbri, M. Zoli, M. Gonzalez-freire, M. E. Salive, S. A. Studenski et al., Aging and Multimorbidity : New Tasks, Priorities, and Frontiers for Integrated Gerontological and Clinical Research, J Am Med Dir Assoc, vol.16, p.640, 2015.

M. E. Salive, Multimorbidity in older adults, Epidemiol Rev, vol.35, pp.75-83, 2013.

C. A. Cadogan, C. Ryan, and C. M. Hughes, Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many, Drug Saf, vol.39, pp.109-125, 2016.

M. Passarelli, J. Filho, W. Figueras, and A. , Adverse drug reactions in an elderly hospitalised population, Drugs Aging, vol.22, pp.767-77, 2005.

I. Klarin, A. Wimo, and J. Fastbom, The Association of Inappropriate Drug Use with Hospitalisation and Mortality. A Population& Based Study of the Very Old, Drugs Aging, vol.22, pp.69-82, 2005.

P. A. Atkin, P. C. Veitch, and E. M. Veitch, The Epidemiology of Serious Adverse Drug Reactions Among the Elderly, Drugs Aging, vol.14, pp.141-152, 1999.

P. A. Routledge, M. S. O'mahony, and W. Et-woodhouse, Adverse drug reactions in elderly patients

, Br J Clin Pharmacol, vol.57, pp.121-126, 2003.

M. L. Laroche, J. P. Charmes, Y. Nouaille, N. Picard, and M. L. , Is inappropriate médication use a major cause of adverse drug reactions in the elderly ?, Br J Clin Pharmacol, vol.63, pp.177-186, 2007.

V. Rollason and N. Vogt, Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist, Drugs Aging, vol.20, pp.817-849, 2003.

H. Autorité-de-santé, Consommation médicamenteuse chez le sujet âgé : consommation, prescription, iatrogénie et observance, 2005.

, Enquêtes Nationales sur les Evénements Indésirables graves associés aux Soins (ENEIS), 2009.

, Updated AGS Beers Criteria® for Potentially InappropriateMedication Use in Older Adults, American Geriatrics Society. American Geriatrics Society, vol.67, pp.674-694, 2019.

M. L. Laroche, J. P. Charmes, and M. L. , Potentially inappropriate medications in the elderly: a French consensus panel list, Eur J Clin Pharmacol, vol.63, pp.725-756, 2007.

P. O. Lang, Les critères STOPP/START v2 : adaptation en langue française, NPG Neurologie-Psychiatrie-Gériatrie, vol.15, pp.323-326, 2015.

S. S. Egger, A. Bachmann, N. Hubmann, R. G. Schlienger, and S. Krähenbühl, Prevalence of Potentially Inappropriate Medication Use in Elderly Patients. Comparison between General Medical and Geriatric Wards, Drugs Aging, vol.23, pp.823-837, 2006.

M. Andro, S. Estivin, and A. Gentric, Analyse qualitative à partir des ordonnances de 200 patients entrant dans un service de court séjour gériatrique. La revue de médecine interne, vol.33, pp.122-149, 2012.

L. Auvray and C. Sermet, Consommations et prescriptions pharmaceutiques chez les personnes âgées, Gérontologie et société, vol.4, pp.13-27, 2002.

, Rapport mondial sur le vieillissement et la santé, 2016.

, Consommation médicamenteuse chez le Sujet Agé, Haute Autorité de Santé (Legrain S), 2005.

H. Autorité-de-santé, Prendre en charge une personne âgée polypathologique en soins primaires, 2015.

, Organisation Mondiale de la Santé. Ma ladie chronique, 2016.

. Legifrance and . Décret, , 1440.

P. Dourgnon, S. Guillaume, and T. Rochereau, Enquête sur la santé et la protection sociale en 2010. Les rapports de l'IRDES, 2012.

, A glossary of terms for community health care and services for older persons, Aging and Health Technical Report, 2004.

S. I. Haider, K. Johnell, G. R. Weitoft, M. Thorslund, and J. Fastbom, The Influence of Educational Level on Polypharmacy and Inappropriate Drug Use: A Register-Based Study of More Than 600,000 Older People, J Am Geriatr Soc, vol.57, pp.62-69, 2009.

T. Grimmsmann and W. Himmel, Polypharmacy in primary care practices: an analysis using a large health insurance database, Pharmacoepidemiol Drug Saf, vol.18, pp.1206-1213, 2009.

K. K. Viktil, H. S. Blix, T. A. Moger, and A. Reikvam, Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems, Br J Clin Pharmacol, vol.63, pp.187-195, 2007.

B. Hovstadius, B. Astrand, and G. Petersson, Dispensed drugs and multiple medications in the Swedish population: an individual-based register study, BMC Clin Pharmacol, p.11, 2009.

. Irdes and . La, polymédication : définitions, mesures et enjeux Revue de la littérature et tests de mesure Questions d'économie de la santé n° 204, 2014.

M. Herr, H. Grondin, S. Sanchez, D. Armaingaud, C. Blochet et al., Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France, Eur J Clin Pharmacol, vol.73, pp.601-608, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01802839

L. Merle, M. L. Laroche, T. Dantoine, and J. P. Charmes, Predicting and preventing adverse drug reactions in the very old, Drugd aging, vol.22, pp.375-392, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01335822

M. L. Laroche, F. Bouthier, L. Merle, and J. P. Charmes, Médicaments potentiellement inappropriés aux personnes âgées : intérêt d'une liste adaptée à la pratique médicale française. La Revue de médecine interne, pp.592-601, 2009.

L. Mo, D. Ding, and S. H. Pu, Patients Aged 80 Years or Older are Encountered More Potentially Inappropriate Medication Use, Chin Med J, vol.129, pp.22-27, 2016.

P. O. Lang, Y. Hasso, J. Belmin, I. Payot, J. P. Baeyens et al., STOPP-START: adaptation of a French language screening tool for detecting inappropriate prescriptions in older people

, Can J Public Health, vol.100, pp.426-431, 2009.

H. Autorité-de-santé, Prescription Médicamenteuse chez le Sujet Agé (PMSA) -Programme Pilote, 2006.

. Haute-autorité-de-santé, . Plan, and . Bien-vieillir, , 2007.

P. Pilote, , 2010.

P. Verger, La politique du médicament en EHPAD, 2013.

, Ministère des Solidarités et de la Santé. Le dispositif PAERPA, 2017.

J. A. Cooper, C. A. Cadogan, S. M. Patterson, N. Kerse, M. C. Bradley et al., Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review, BMJ Open, vol.5, p.9235, 2015.

E. C. Lehnbom, M. J. Stewart, E. Manias, and J. I. Westbrook, Impact of medication reconciliation and review on clinical outcomes, Ann Pharmacother, vol.48, pp.1298-1312, 2014.

S. M. Patterson, C. A. Cadogan, N. Kerse, C. R. Cardwell, M. C. Bradley et al., Interventions to improve the appropriate use of polypharmacy for older people, Cochrane Database Syst Rev, p.8165, 2014.

H. Autorité-de-santé, Prescrire chez le sujet âgé (plus de 75 ans ou plus de 65 ans et polypathologique)

A. Spinewine, K. E. Schmader, N. Barber, C. Hughes, K. L. Lapane et al., Appropriate prescribing in elderly people: how well can it be measured and optimised ? The Lancet, vol.370, pp.173-184, 2007.

M. H. Beers, J. G. Ouslander, I. Rollingher, D. B. Reuben, J. Brooks et al., Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine, Arch Intern Med, vol.151, pp.1825-1832, 1991.

, Beers MH Explicit criteria for determining potentially inappropriate medication use by the elderly. An update, Arch Intern Med, vol.157, pp.1531-1536, 1997.

D. M. Fick, J. W. Cooper, W. E. Wade, J. L. Waller, J. R. Maclean et al., Updating the Beers criteria for potentially inappropriate medication use in older adults : results of a US consensus panel of experts, Arch Intern Med, vol.163, pp.2716-2724, 2003.

D. Fick, T. Semla, J. Beizer, N. Brandt, R. Dombrowski et al., American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults, J Am Geriatr Soc, vol.60, pp.616-631, 2012.

R. L. Salbu, J. Feuer, and . Closer, Look at the 2015 Beers Criteria, J Pharm Pract, vol.30, pp.419-424, 2017.

P. J. Mcleod, A. R. Huang, R. M. Tamblyn, and D. C. Gayton, Defining inappropriate practices in prescribing for elderly people: a national consensus panel, Can Med Assoc J, vol.156, pp.385-391, 1997.

C. T. Naugler, C. Brymer, P. Stolee, and Z. A. Arcese, Development and validation of an improving prescribing in the elderly tool Can, J Clin Pharmacol, vol.7, pp.103-107, 2000.

C. Zhan, J. Sangl, A. S. Bierman, M. R. Miller, B. Friedman et al., Potentially inappropriate medication use in the community-dwelling elderly, 1996.

, Medical Expenditure Panel Survey. J Am Med Ass, vol.286, pp.2823-2832, 2001.

S. Rognstad, M. Brekke, A. Fetveit, O. Spigset, T. B. Wyller et al., The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study, Scand J Pirm Health Care, vol.27, pp.153-159, 2009.

H. B. Levy, E. L. Marcus, and C. Christen, Beyond the Beers criteria: a comparative overview of explicit criteria, Ann Pharmacother, vol.44, pp.1968-1975, 2010.

A. Lara, E. R. Vega-coca, M. D. , G. Banqueri, M. et al., Selection of tools for reconciliation, compliance and appropriateness of treatment in patients with multiple chronic conditions, Eur J Intern Med, vol.23, pp.506-512, 2012.

W. Vermeulen, M. M. Verduijn, H. J. Derijks, V. Marum, and R. J. , Detection of inappropriate medication use in the elderly; will the STOPP and START criteria become the new Dutch standards, Ned Tijdschr Geneeskd, vol.156, p.5076, 2012.

, Agence Nationale du Médicament et des Produits de Santé. Bon usage des agents antiplaquettaires, 2012.

E. Society and . Cardiology, CVD Prevention in Clinical Practice (European Guidelines on, 2017.

, Guideline on the Primary Prevention of Cardiovascular Disease, American College of Cardiology/American Heart Association, 2019.

,

C. Manes, L. Giacci, A. Sciartilli, D. 'alleva, A. et al., Aspirin overprescription in primary cardiovascular prevention, Thromb Res, vol.118, pp.471-477, 2006.

O. Dalleur, Aspirin misuse at home according to the START and STOPP in frail older persons, European Geriatric Medicine, 2012.

M. Andro, S. Estivin, and A. Gentric, Analyse qualitative à partir des ordonnances de200 patients entrant dans un service de court séjour gériatrique. La revue de médecine interne, vol.33, pp.122-149, 2012.

E. Gentes, Grandes fréquences des prescriptions médicamenteuses à visée cardiovasculaire potentiellement inappropriées dans la population âgée. La Presse Médicale, 2015.

R. S. Hira, K. Kennedy, V. Nambi, H. Jneid, M. Alam et al., Frequency and practicelevel variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry, J Am Coll Cardiol, vol.65, pp.111-121, 2015.

, ESC Clinical Practice Guidelines. Management of atrial fibrillation, 2016.

. Ansm, Analyse des ventes de médicaments en France en 2013, 2014.